Cargando…

2020년 개정 진료 치침에 따른 과민성폐렴의 진단

Hypersensitivity pneumonitis (HP) is an interstitial lung disease (ILD) characterized by an inhaled inciting antigen that leads to the inflammation of the lung parenchyma and small airway with immunologic reactions. Over the last decades, the most effective therapeutic option for HP has been limited...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514409/
https://www.ncbi.nlm.nih.gov/pubmed/36238061
http://dx.doi.org/10.3348/jksr.2021.0075
_version_ 1784798267963342848
collection PubMed
description Hypersensitivity pneumonitis (HP) is an interstitial lung disease (ILD) characterized by an inhaled inciting antigen that leads to the inflammation of the lung parenchyma and small airway with immunologic reactions. Over the last decades, the most effective therapeutic option for HP has been limited to antigen avoidance. The differential diagnosis of HP from other ILDs is the beginning of treatment as well as diagnosis. However, the presence of several overlapping clinical and radiologic features makes differentiating HP from other ILDs particularly challenging. In 2020, a multidisciplinary committee of experts from the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax suggested a new clinical practice guideline classifying HP into nonfibrotic and fibrotic phenotypes on the basis of chest high-resolution CT (HRCT) findings. Therefore, we introduced a new diagnostic algorithm based on chest HRCT in the clinical practice guideline for the diagnosis of HP.
format Online
Article
Text
id pubmed-9514409
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Society of Radiology
record_format MEDLINE/PubMed
spelling pubmed-95144092022-10-12 2020년 개정 진료 치침에 따른 과민성폐렴의 진단 Taehan Yongsang Uihakhoe Chi Updates in Chest Radiology Hypersensitivity pneumonitis (HP) is an interstitial lung disease (ILD) characterized by an inhaled inciting antigen that leads to the inflammation of the lung parenchyma and small airway with immunologic reactions. Over the last decades, the most effective therapeutic option for HP has been limited to antigen avoidance. The differential diagnosis of HP from other ILDs is the beginning of treatment as well as diagnosis. However, the presence of several overlapping clinical and radiologic features makes differentiating HP from other ILDs particularly challenging. In 2020, a multidisciplinary committee of experts from the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax suggested a new clinical practice guideline classifying HP into nonfibrotic and fibrotic phenotypes on the basis of chest high-resolution CT (HRCT) findings. Therefore, we introduced a new diagnostic algorithm based on chest HRCT in the clinical practice guideline for the diagnosis of HP. The Korean Society of Radiology 2021-07 2021-07-26 /pmc/articles/PMC9514409/ /pubmed/36238061 http://dx.doi.org/10.3348/jksr.2021.0075 Text en Copyrights © 2021 The Korean Society of Radiology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Updates in Chest Radiology
2020년 개정 진료 치침에 따른 과민성폐렴의 진단
title 2020년 개정 진료 치침에 따른 과민성폐렴의 진단
title_full 2020년 개정 진료 치침에 따른 과민성폐렴의 진단
title_fullStr 2020년 개정 진료 치침에 따른 과민성폐렴의 진단
title_full_unstemmed 2020년 개정 진료 치침에 따른 과민성폐렴의 진단
title_short 2020년 개정 진료 치침에 따른 과민성폐렴의 진단
title_sort 2020년 개정 진료 치침에 따른 과민성폐렴의 진단
topic Updates in Chest Radiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514409/
https://www.ncbi.nlm.nih.gov/pubmed/36238061
http://dx.doi.org/10.3348/jksr.2021.0075
work_keys_str_mv AT 2020nyeongaejeongjinlyochichimettaleungwaminseongpyelyeomuijindan
AT 2020nyeongaejeongjinlyochichimettaleungwaminseongpyelyeomuijindan
AT 2020nyeongaejeongjinlyochichimettaleungwaminseongpyelyeomuijindan
AT 2020nyeongaejeongjinlyochichimettaleungwaminseongpyelyeomuijindan
AT 2020nyeongaejeongjinlyochichimettaleungwaminseongpyelyeomuijindan
AT 2020nyeongaejeongjinlyochichimettaleungwaminseongpyelyeomuijindan
AT 2020nyeongaejeongjinlyochichimettaleungwaminseongpyelyeomuijindan